StockClub

LYEL

LYELLyell Immunopharma, Inc.$ --
Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc.

LYEL

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -71.4%
Operating Income
-46M USD
YoY +19.5%
Net Income
-24M USD
YoY +53.7%
EPS
-1.1$
YoY -511.1%

Revenue

$2,000
FY2024 Q2$16,000
$16,000
Q2
FY2024 Q3$50,000
$50,000
Q3
FY2024 Q4$61,000
$61,000
Q4
FY2025 Q1$7,000
$7,000
Q1
FY2025 Q2$15,000
$15,000
Q2
FY2025 Q3$30,000
$30,000
Q3
FY2025 Q4$36,000
$36,000
Q4
FY2026 Q1$2,000
$2,000
Q1
Actual
$-5,000 (-71.4%)

Net Income

$-24.2M
FY2024 Q2$-106.5M
$-106.5M
Q2
FY2024 Q3$-151.1M
$-151.1M
Q3
FY2024 Q4$-343M
$-343M
Q4
FY2025 Q1$-52.2M
$-52.2M
Q1
FY2025 Q2$-94.9M
$-94.9M
Q2
FY2025 Q3$-133.7M
$-133.7M
Q3
FY2025 Q4$-274.4M
$-274.4M
Q4
FY2026 Q1$-24.2M
$-24.2M
Q1
Actual
+$28M (+53.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$7.8M
FY2020
$7.8M
FY2021BEAT
Actual:$10.7M
Est:$9.4M
FY2021BEAT
$10.7M
FY2022BEAT
Actual:$84.7M
Est:$49.3M
FY2022BEAT
$84.7M
FY2023BEAT
Actual:$130,000
Est:$54,000
FY2023BEAT
$130,000
FY2024BEAT
Actual:$61,000
Est:$49,000
FY2024BEAT
$61,000
FY2025MISS
Actual:$36,000
Est:$36,200
FY2025MISS
$36,000

Analyst Estimates